Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Decreases Escherichia coli O2:K1:H7 - : origanum vulgare {oregano} |
👶
In-vitro antimicrobial activity and identification of bioactive components using GC-MS of commercially available essential oils in Saudi Arabia. Journal of food science and technology (J Food Sci Technol ) Vol: 54 Issue 12 Pages: 3948-3958 Pub: 2017 Nov Epub: 2017 Sep 21 Authors Ashraf SA , Al-Shammari E , Hussain T , Tajuddin S , Panda BP , Html Article Publication |
| Decreases Escherichia coli O2:K1:H7 - : origanum vulgare {oregano} |
👶
In vitro antimicrobial activity of five essential oils on multidrug resistant Gram-negative clinical isolates. Journal of intercultural ethnopharmacology (J Intercult Ethnopharmacol ) Vol: 5 Issue 3 Pages: 212-8 Pub: 2016 Jun-Aug Epub: 2016 May 30 Authors Sakkas H , Gousia P , Economou V , Sakkas V , Petsios S , Papadopoulou C , Html Article Publication |
| Decreases Escherichia coli O2:K1:H7 - : origanum vulgare {oregano} |
👶
Antimicrobial Activity of Five Essential Oils against Bacteria and Fungi Responsible for Urinary Tract Infections. Molecules (Basel, Switzerland) (Molecules ) Vol: 23 Issue 7 Pages: Pub: 2018 Jul 9 Epub: 2018 Jul 9 Authors Ebani VV , Nardoni S , Bertelloni F , Pistelli L , Mancianti F , Html Article Publication |
| Decreases Escherichia coli O2:K1:H7 - : origanum vulgare {oregano} |
👶
Phytochemical Screening and Antimicrobial Activity of Some Medicinal Plants Against Multi-drug Resistant Bacteria from Clinical Isolates. Indian journal of pharmaceutical sciences (Indian J Pharm Sci ) Vol: 74 Issue 5 Pages: 443-50 Pub: 2012 Sep Epub: Authors Dahiya P , Purkayastha S , Html Article Publication |
| Decreases Escherichia coli O2:K1:H7 - : origanum vulgare {oregano} |
👶
Antimicrobial Activity of Origanum vulgare Essential Oil against Staphylococcus aureus and Escherichia coli. Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 17 Issue 11 Pages: Pub: 2024 Oct 25 Epub: 2024 Oct 25 Authors Tejada-Muñoz S , Cortez D , Rascón J , Chavez SG , Caetano AC , Díaz-Manchay RJ , Sandoval-Bances J , Huyhua-Gutierrez S , Gonzales L , Chenet SM , Tapia-Limonchi R , Html Article Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
